BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Summary of revenues disaggregated by our business operations and timing of revenue recognition (Details) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue
Total	$ 6,147,283	$ 2,671,542	$ 10,312,989	$ 4,287,683
Research and development services (over-time)
Disaggregation of Revenue
Total	219,898	124,760	325,591	388,473
Clinical laboratory testing services (point-in-time)
Disaggregation of Revenue
Total	4,331,867	1,425,980	6,205,589	2,003,250
Clinical laboratory testing services (over-time)
Disaggregation of Revenue
Total	1,158,375	128,900	2,484,775	324,400
Supply chain
Disaggregation of Revenue
Total	115,463	67,057	527,295	99,999
Asset marking
Disaggregation of Revenue
Total	141,657	140,169	246,895	291,927
Diagnostic test kits
Disaggregation of Revenue
Total	$ 180,023	$ 784,676	$ 522,844	$ 1,179,634